About me
John Chiminski was named Chief Executive Officer of Catalent, Inc. in March 2009 and appointed Chair of the Catalent Board in October 2016. He then served as Catalent’s Executive Chair from June 2022 to June 2023, as part of a planned succession of a new CEO and transition to an independent Chair of the Catalent BoD.
Mr. Chiminski partnered with the PE firm Blackstone to complete a carve-out of the Catalent business from Cardinal Health and transform it to its current position as a market leader in biopharma services. Included in that transformation was a successful IPO in 2014 and the transition to a fully independent public company in October 2016. Under a decade of his leadership, Catalent’s revenue grew 8% CAGR at constant currency and its enterprise value more than quintupled to $18.5 billion.
Mr. Chiminski has a diversified medical diagnostics and pharmaceutical background that includes operations leadership, product development and services, with a track record of growing global businesses.
He joined Catalent after more than 20 years at GE Healthcare. From 2007 until 2009, Mr. Chiminski served as President and CEO of GE Medical Diagnostics, a global business with sales of $1.9 billion. From 2005 to 2007, he served as Vice President and General Manager of GE Healthcare’s global magnetic resonance business, and, from 2001 to 2005, Mr. Chiminski served as Vice President and General Manager of Global Healthcare Services. Earlier in his career, Mr. Chiminski held a series of cross-functional leadership positions in both operations and engineering, including GE Medical Systems assignments in France.
Mr. Chiminski holds a bachelor’s degree from Michigan State University and a master’s degree from Purdue University, both in electrical engineering, as well as a master’s degree in management from the Kellogg School of Management at Northwestern University. In 2012, he received a Distinguished Engineering Alumni award from Purdue for his record of accomplishments. In 2019, Mr. Chiminski was the first recipient of the CPhI Lifetime Achievement Award for a distinguished career in the biotech or pharmaceutical arena. He is a Senior Advisor at Abingworth, a bioscience investment firm, and previously served as a director of PhenomeX, DJO Global as well as Graham Packaging. Married with three children, Mr. Chiminski lives in Southeastern Florida.
